speb/financial-data huggingface dataset:
GENI.L balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 95816866.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Equity Interest: 73000.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 193000.00
GENI.L income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 2000.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Payable: 137000.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Properties: 51000.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Receivables: 31000.00
GENI.L balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 4000.00
GENI.L income_statement (annual, 2021-12-31) — Other Special Charges: 612000.00
GENI.L income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENI.L balance_sheet (annual, 2021-12-31) — Payables: 582000.00
GENI.L balance_sheet (annual, 2021-12-31) — Prepaid Assets: 134000.00
GENI.L income_statement (annual, 2021-12-31) — Pretax Income: -4136000.00
GENI.L balance_sheet (annual, 2021-12-31) — Properties: 0.00
GENI.L cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -104000.00
GENI.L cash_flow (annual, 2021-12-31) — Purchase Of PPE: -41000.00
GENI.L income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 561000.00
GENI.L income_statement (annual, 2021-12-31) — Reconciled Depreciation: 35000.00
GENI.L income_statement (annual, 2021-12-31) — Rent And Landing Fees: 202000.00
GENI.L income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 202000.00
GENI.L balance_sheet (annual, 2021-12-31) — Retained Earnings: -2936000.00
GENI.L income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 134000.00
GENI.L income_statement (annual, 2021-12-31) — Selling General And Administration: 2142000.00
GENI.L balance_sheet (annual, 2021-12-31) — Share Issued: 95816866.00
GENI.L income_statement (annual, 2021-12-31) — Special Income Charges: -612000.00
GENI.L cash_flow (annual, 2021-12-31) — Stock Based Compensation: 73000.00
GENI.L balance_sheet (annual, 2021-12-31) — Stockholders Equity: 13718000.00
GENI.L balance_sheet (annual, 2021-12-31) — Tangible Book Value: 13525000.00
GENI.L income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: -116280.00
GENI.L income_statement (annual, 2021-12-31) — Tax Provision: 6000.00
GENI.L income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.19
GENI.L balance_sheet (annual, 2021-12-31) — Total Assets: 15210000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Capitalization: 13718000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Debt: 0.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 13718000.00
GENI.L income_statement (annual, 2021-12-31) — Total Expenses: 4688000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 1492000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 239000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 661000.00
GENI.L income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -4146000.00
GENI.L income_statement (annual, 2021-12-31) — Total Other Finance Cost: -2000.00
GENI.L balance_sheet (annual, 2021-12-31) — Total Tax Payable: 100000.00
GENI.L income_statement (annual, 2021-12-31) — Total Unusual Items: -612000.00
GENI.L income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -612000.00
GENI.L balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 661000.00
GENI.L balance_sheet (annual, 2021-12-31) — Working Capital: 14140000.00
GENI.L income_statement (annual, 2022-12-31) — +Operating Expense: 6531000.00
GENI.L income_statement (annual, 2022-12-31) — +Total Revenue: 1430000.00
GENI.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 1416000.00
GENI.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 315000.00
GENI.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -140000.00
GENI.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 15551000.00
GENI.L income_statement (annual, 2022-12-31) — Amortization: 59000.00
GENI.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 32000.00
GENI.L income_statement (annual, 2022-12-31) — Basic Average Shares: 95816866.00
GENI.L income_statement (annual, 2022-12-31) — Basic EPS: -0.06
GENI.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 14554000.00
GENI.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 387000.00
GENI.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -849000.00
GENI.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 354000.00
GENI.L balance_sheet (annual, 2022-12-31) — Capital Stock: 958000.00
GENI.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9732000.00
GENI.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9748000.00
GENI.L cash_flow (annual, 2022-12-31) — Change In Inventory: -6000.00
GENI.L cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -13000.00
GENI.L cash_flow (annual, 2022-12-31) — Change In Payable: 2021000.00
GENI.L cash_flow (annual, 2022-12-31) — Change In Receivables: -106000.00
GENI.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 1896000.00
GENI.L cash_flow (annual, 2022-12-31) — Changes In Cash: -4461000.00
GENI.L balance_sheet (annual, 2022-12-31) — Common Stock: 958000.00
GENI.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7900000.00
GENI.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
GENI.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 798000.00
GENI.L balance_sheet (annual, 2022-12-31) — Current Assets: 10485000.00
GENI.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 69000.00
GENI.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 69000.00
GENI.L balance_sheet (annual, 2022-12-31) — Current Deferred Taxes Liabilities: 31000.00
GENI.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 2178000.00
GENI.L cash_flow (annual, 2022-12-31) — Deferred Tax: 0.00
GENI.L cash_flow (annual, 2022-12-31) — Depreciation: 131000.00
GENI.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 163000.00
GENI.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 163000.00
GENI.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 104000.00
GENI.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 95816866.00
GENI.L income_statement (annual, 2022-12-31) — Diluted EPS: -0.06
GENI.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -5559000.00
GENI.L income_statement (annual, 2022-12-31) — EBIT: -5726000.00
GENI.L income_statement (annual, 2022-12-31) — EBITDA: -5563000.00
GENI.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -361000.00
GENI.L cash_flow (annual, 2022-12-31) — End Cash Position: 9732000.00
GENI.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -47000.00
GENI.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -4574000.00
GENI.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
GENI.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 3181000.00
GENI.L balance_sheet (annual, 2022-12-31) — Goodwill: 149000.00
GENI.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 310000.00
GENI.L balance_sheet (annual, 2022-12-31) — Gross PPE: 1142000.00
GENI.L income_statement (annual, 2022-12-31) — Gross Profit: 632000.00
GENI.L income_statement (annual, 2022-12-31) — Interest Expense: 20000.00
GENI.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 20000.00
GENI.L income_statement (annual, 2022-12-31) — Interest Income: 160000.00
GENI.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 160000.00
GENI.L cash_flow (annual, 2022-12-31) — Interest Received Cfi: 160000.00
GENI.L balance_sheet (annual, 2022-12-31) — Inventory: 20000.00
GENI.L balance_sheet (annual, 2022-12-31) — Invested Capital: 7900000.00
GENI.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -689000.00
GENI.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
GENI.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 285000.00
GENI.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 285000.00
GENI.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 755000.00
GENI.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
GENI.L cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -197000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income: -5559000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -5559000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -5559000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -5559000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -5559000.00
GENI.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -5745000.00
GENI.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -5559000.00
GENI.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -149000.00
GENI.L income_statement (annual, 2022-12-31) — Net Interest Income: 140000.00
GENI.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 140000.00
GENI.L balance_sheet (annual, 2022-12-31) — Net PPE: 1002000.00
GENI.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -700000.00
GENI.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7590000.00
GENI.L income_statement (annual, 2022-12-31) — Normalized EBITDA: -5563000.00
GENI.L income_statement (annual, 2022-12-31) — Normalized Income: -5559000.00
GENI.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3725000.00
GENI.L income_statement (annual, 2022-12-31) — Operating Income: -5899000.00
GENI.L income_statement (annual, 2022-12-31) — Operating Revenue: 1430000.00
GENI.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 95816866.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: 175000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 161000.00
GENI.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: -141000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Non Current Assets: -1000.00
GENI.L income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 13000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Payable: 76000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Properties: 1099000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Receivables: 299000.00
GENI.L balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 16000.00
GENI.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENI.L balance_sheet (annual, 2022-12-31) — Payables: 1646000.00
GENI.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 103000.00
GENI.L income_statement (annual, 2022-12-31) — Pretax Income: -5746000.00
GENI.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
GENI.L cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -149000.00
GENI.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -700000.00
GENI.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 798000.00
GENI.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 163000.00
GENI.L income_statement (annual, 2022-12-31) — Rent And Landing Fees: 667000.00
GENI.L income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 667000.00
GENI.L balance_sheet (annual, 2022-12-31) — Retained Earnings: -8495000.00
GENI.L income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 145000.00
GENI.L income_statement (annual, 2022-12-31) — Selling General And Administration: 3326000.00
GENI.L balance_sheet (annual, 2022-12-31) — Share Issued: 95816866.00
GENI.L income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
GENI.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 102000.00
GENI.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7900000.00
GENI.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 7590000.00
GENI.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
GENI.L income_statement (annual, 2022-12-31) — Tax Provision: -187000.00
GENI.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.03
GENI.L balance_sheet (annual, 2022-12-31) — Total Assets: 11797000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 7900000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Debt: 354000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7900000.00
GENI.L income_statement (annual, 2022-12-31) — Total Expenses: 7329000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3897000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1312000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1719000.00
GENI.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -5899000.00
GENI.L income_statement (annual, 2022-12-31) — Total Other Finance Cost: -7000.00
GENI.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 154000.00
GENI.L income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
GENI.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GENI.L balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 1434000.00
GENI.L balance_sheet (annual, 2022-12-31) — Working Capital: 8307000.00
GENI.L income_statement (annual, 2023-12-31) — +Operating Expense: 8173000.00
GENI.L income_statement (annual, 2023-12-31) — +Total Revenue: 2160000.00
GENI.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 1194000.00
GENI.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 428000.00
GENI.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -462000.00
GENI.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15551000.00
GENI.L income_statement (annual, 2023-12-31) — Amortization: 105000.00
GENI.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 105000.00
GENI.L income_statement (annual, 2023-12-31) — Basic Average Shares: 95816866.00
GENI.L income_statement (annual, 2023-12-31) — Basic EPS: -0.07
GENI.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 9732000.00
GENI.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 402000.00
GENI.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -38000.00
GENI.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 299000.00
GENI.L balance_sheet (annual, 2023-12-31) — Capital Stock: 958000.00
GENI.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2484000.00
GENI.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2526000.00
GENI.L cash_flow (annual, 2023-12-31) — Change In Inventory: -65000.00
GENI.L cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -26000.00
GENI.L cash_flow (annual, 2023-12-31) — Change In Payable: -1071000.00
GENI.L cash_flow (annual, 2023-12-31) — Change In Receivables: 383000.00
GENI.L cash_flow (annual, 2023-12-31) — Change In Working Capital: -779000.00
GENI.L cash_flow (annual, 2023-12-31) — Changes In Cash: -7464000.00
GENI.L balance_sheet (annual, 2023-12-31) — Common Stock: 958000.00
GENI.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1289000.00
GENI.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
GENI.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 1138000.00
GENI.L balance_sheet (annual, 2023-12-31) — Current Assets: 3192000.00
GENI.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 78000.00
GENI.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 78000.00
GENI.L balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Liabilities: 25000.00
GENI.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 2473000.00
GENI.L cash_flow (annual, 2023-12-31) — Deferred Tax: 0.00
GENI.L cash_flow (annual, 2023-12-31) — Depreciation: 246000.00
GENI.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 351000.00
GENI.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 351000.00
GENI.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 246000.00
GENI.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 95816866.00
GENI.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.07
GENI.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -7016000.00
GENI.L income_statement (annual, 2023-12-31) — EBIT: -6975000.00
GENI.L income_statement (annual, 2023-12-31) — EBITDA: -6624000.00
GENI.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 216000.00
GENI.L cash_flow (annual, 2023-12-31) — End Cash Position: 2484000.00
GENI.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -94000.00
GENI.L cash_flow (annual, 2023-12-31) — Free Cash Flow: -7544000.00
GENI.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 3342000.00
GENI.L balance_sheet (annual, 2023-12-31) — Goodwill: 149000.00
GENI.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 287000.00
GENI.L balance_sheet (annual, 2023-12-31) — Gross PPE: 1169000.00
GENI.L income_statement (annual, 2023-12-31) — Gross Profit: 1022000.00
GENI.L income_statement (annual, 2023-12-31) — Interest Expense: 48000.00
GENI.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 48000.00
GENI.L income_statement (annual, 2023-12-31) — Interest Income: 174000.00
GENI.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 174000.00
GENI.L cash_flow (annual, 2023-12-31) — Interest Received Cfi: 174000.00
GENI.L balance_sheet (annual, 2023-12-31) — Inventory: 84000.00
GENI.L balance_sheet (annual, 2023-12-31) — Invested Capital: 1289000.00
GENI.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: 136000.00
GENI.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
GENI.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 221000.00
GENI.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 221000.00
GENI.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 767000.00
GENI.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
GENI.L income_statement (annual, 2023-12-31) — Net Income: -7016000.00
GENI.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -7016000.00
GENI.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -7016000.00
GENI.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -7016000.00
GENI.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -7016000.00
GENI.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -7023000.00
GENI.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -7016000.00
GENI.L cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
GENI.L income_statement (annual, 2023-12-31) — Net Interest Income: 126000.00
GENI.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 126000.00
GENI.L balance_sheet (annual, 2023-12-31) — Net PPE: 707000.00
GENI.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -38000.00
GENI.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1002000.00
GENI.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 25000.00
GENI.L income_statement (annual, 2023-12-31) — Normalized EBITDA: -6624000.00
GENI.L income_statement (annual, 2023-12-31) — Normalized Income: -7016000.00
GENI.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7506000.00
GENI.L income_statement (annual, 2023-12-31) — Operating Income: -7151000.00
GENI.L income_statement (annual, 2023-12-31) — Operating Revenue: 2160000.00
GENI.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 95816866.00
GENI.L balance_sheet (annual, 2023-12-31) — Other Equity Interest: 246000.00
GENI.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 138000.00
GENI.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: -126000.00
GENI.L income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2000.00
GENI.L balance_sheet (annual, 2023-12-31) — Other Payable: 622000.00
GENI.L balance_sheet (annual, 2023-12-31) — Other Receivables: 81000.00
GENI.L balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 42000.00
GENI.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENI.L balance_sheet (annual, 2023-12-31) — Payables: 1999000.00
GENI.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 73000.00
GENI.L income_statement (annual, 2023-12-31) — Pretax Income: -7023000.00
GENI.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
GENI.L cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
GENI.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -38000.00
GENI.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1138000.00
GENI.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 351000.00
GENI.L income_statement (annual, 2023-12-31) — Rent And Landing Fees: 696000.00
GENI.L income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 696000.00
GENI.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -15511000.00
GENI.L income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 379000.00
GENI.L income_statement (annual, 2023-12-31) — Selling General And Administration: 3721000.00
GENI.L balance_sheet (annual, 2023-12-31) — Share Issued: 95816866.00
GENI.L income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
GENI.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 71000.00
GENI.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1289000.00
GENI.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1002000.00
GENI.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
GENI.L income_statement (annual, 2023-12-31) — Tax Provision: -7000.00
GENI.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
GENI.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 0.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Assets: 4186000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 1289000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Debt: 299000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1289000.00
GENI.L income_statement (annual, 2023-12-31) — Total Expenses: 9311000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2897000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 994000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 424000.00
GENI.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7151000.00
GENI.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 183000.00
GENI.L income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
GENI.L income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GENI.L balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 178000.00
GENI.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
GENI.L balance_sheet (annual, 2023-12-31) — Working Capital: 719000.00
GENI.L income_statement (annual, 2024-12-31) — +Operating Expense: 6437000.00
GENI.L income_statement (annual, 2024-12-31) — +Total Revenue: 2701000.00
GENI.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 612000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 612000.00
GENI.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 540000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 540000.00
GENI.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -794000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -794000.00
GENI.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 18482000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 18482000.00
GENI.L income_statement (annual, 2024-12-31) — Amortization: 107000.00
GENI.L cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 107000.00
GENI.L income_statement (annual, 2024-12-31) — Basic Average Shares: 175023256.00
GENI.L income_statement (annual, 2024-12-31) — Basic EPS: -0.03
GENI.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2484000.00
GENI.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 414000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 414000.00
GENI.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -49000.00
GENI.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 234000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 234000.00
GENI.L balance_sheet (annual, 2024-12-31) — Capital Stock: 1770000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1770000.00
GENI.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1110000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1110000.00
GENI.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1165000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1165000.00
GENI.L cash_flow (annual, 2024-12-31) — Change In Inventory: -42000.00
GENI.L cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -13000.00
GENI.L cash_flow (annual, 2024-12-31) — Change In Payable: -1077000.00
GENI.L cash_flow (annual, 2024-12-31) — Change In Receivables: -231000.00
GENI.L cash_flow (annual, 2024-12-31) — Change In Working Capital: -1363000.00
GENI.L cash_flow (annual, 2024-12-31) — Changes In Cash: -1478000.00
GENI.L balance_sheet (annual, 2024-12-31) — Common Stock: 1770000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 1770000.00
GENI.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1127000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1127000.00
GENI.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 3743000.00
GENI.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 1275000.00
GENI.L balance_sheet (annual, 2024-12-31) — Current Assets: 2104000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 2104000.00
GENI.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 87000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 87000.00
GENI.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 87000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 87000.00
GENI.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 1377000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1377000.00
GENI.L cash_flow (annual, 2024-12-31) — Depreciation: 240000.00
GENI.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 347000.00
GENI.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 347000.00
GENI.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 240000.00
GENI.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 175023256.00
GENI.L income_statement (annual, 2024-12-31) — Diluted EPS: -0.03
GENI.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — EBIT: -5035000.00
GENI.L income_statement (annual, 2024-12-31) — EBITDA: -4688000.00
GENI.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 104000.00
GENI.L cash_flow (annual, 2024-12-31) — End Cash Position: 1110000.00
GENI.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3645000.00
GENI.L cash_flow (annual, 2024-12-31) — Free Cash Flow: -5222000.00
GENI.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 1676000.00
GENI.L balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
GENI.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 118000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 118000.00
GENI.L balance_sheet (annual, 2024-12-31) — Gross PPE: 1235000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1235000.00
GENI.L income_statement (annual, 2024-12-31) — Gross Profit: 1426000.00
GENI.L income_statement (annual, 2024-12-31) — Interest Expense: 48000.00
GENI.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 48000.00
GENI.L income_statement (annual, 2024-12-31) — Interest Income: 98000.00
GENI.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 98000.00
GENI.L cash_flow (annual, 2024-12-31) — Interest Received Cfi: 99000.00
GENI.L balance_sheet (annual, 2024-12-31) — Inventory: 126000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Inventory: 126000.00
GENI.L balance_sheet (annual, 2024-12-31) — Invested Capital: 1127000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 1127000.00
GENI.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: 50000.00
GENI.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 3743000.00
GENI.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 147000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 147000.00
GENI.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 147000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 147000.00
GENI.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 821000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 821000.00
GENI.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 3743000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4434000.00
GENI.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -5083000.00
GENI.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -4434000.00
GENI.L income_statement (annual, 2024-12-31) — Net Interest Income: 50000.00
GENI.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 50000.00
GENI.L balance_sheet (annual, 2024-12-31) — Net PPE: 441000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 441000.00
GENI.L cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -49000.00
GENI.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1009000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1009000.00
GENI.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 12000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 12000.00
GENI.L income_statement (annual, 2024-12-31) — Normalized EBITDA: -4745000.00
GENI.L income_statement (annual, 2024-12-31) — Normalized Income: -4483722.21
GENI.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: -5173000.00
GENI.L income_statement (annual, 2024-12-31) — Operating Income: -5011000.00
GENI.L income_statement (annual, 2024-12-31) — Operating Revenue: 2701000.00
GENI.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 176964426.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 176964426.00
GENI.L balance_sheet (annual, 2024-12-31) — Other Equity Interest: 643000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 643000.00
GENI.L balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 118000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 118000.00
GENI.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: -51000.00
GENI.L income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1000.00
GENI.L balance_sheet (annual, 2024-12-31) — Other Payable: 11000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 11000.00
GENI.L balance_sheet (annual, 2024-12-31) — Other Receivables: 70000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 70000.00
GENI.L balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 55000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 55000.00
GENI.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
GENI.L balance_sheet (annual, 2024-12-31) — Payables: 780000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Payables: 780000.00
GENI.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 203000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 203000.00
GENI.L income_statement (annual, 2024-12-31) — Pretax Income: -5083000.00
GENI.L balance_sheet (annual, 2024-12-31) — Properties: 0.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
GENI.L cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -206000.00
GENI.L cash_flow (annual, 2024-12-31) — Purchase Of PPE: -49000.00
GENI.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1275000.00
GENI.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 347000.00
GENI.L income_statement (annual, 2024-12-31) — Rent And Landing Fees: 739000.00
GENI.L income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 739000.00
GENI.L income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -206000.00
GENI.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -19945000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -19945000.00
GENI.L income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 249000.00
GENI.L income_statement (annual, 2024-12-31) — Selling General And Administration: 1925000.00
GENI.L balance_sheet (annual, 2024-12-31) — Share Issued: 176964426.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 176964426.00
GENI.L income_statement (annual, 2024-12-31) — Special Income Charges: 57000.00
GENI.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 397000.00
GENI.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1127000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1127000.00
GENI.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1009000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1009000.00
GENI.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 7277.79
GENI.L income_statement (annual, 2024-12-31) — Tax Provision: -649000.00
GENI.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.13
GENI.L cash_flow (annual, 2024-12-31) — Taxes Refund Paid: 637000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Assets: 2663000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 2663000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Capitalization: 1127000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 1127000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Debt: 234000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 234000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1127000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1127000.00
GENI.L income_statement (annual, 2024-12-31) — Total Expenses: 7712000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1536000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 1536000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 559000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 559000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 159000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 159000.00
GENI.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -5134000.00
GENI.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 157000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 157000.00
GENI.L income_statement (annual, 2024-12-31) — Total Unusual Items: 57000.00
GENI.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 57000.00
GENI.L balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 0.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 0.00
GENI.L balance_sheet (annual, 2024-12-31) — Working Capital: 727000.00
GENI.L balance_sheet (quarterly, 2024-12-31) — Working Capital: 727000.00
GENI.L income_statement (annual, 2024-12-31) — Write Off: 149000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1360000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1229000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 21126000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 191000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2869000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2438000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2503000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 2869000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2663000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 3827000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 0.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Liabilities: 7000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1367000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Goodwill: 0.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 108000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Gross PPE: 286000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Inventory: 95000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2663000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 191000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 191000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 286000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2555000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 899000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 108000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Other Properties: 286000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 65000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Payables: 1360000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -22908000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2663000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2555000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 4221000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2663000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 191000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2663000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1558000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 394000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 191000.00
GENI.L balance_sheet (quarterly, 2025-06-30) — Working Capital: 2460000.00
GENI.L income_statement (annual, 2025-12-31) — +Operating Expense: 7453000.00
GENI.L income_statement (annual, 2025-12-31) — +Total Revenue: 3076000.00
GENI.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 1278000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1278000.00
GENI.L balance_sheet (annual, 2025-12-31) — Accounts Receivable: 857000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 857000.00
GENI.L balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1011000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1011000.00
GENI.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 21126000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 21126000.00
GENI.L income_statement (annual, 2025-12-31) — Amortization: 103000.00
GENI.L cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 103000.00
GENI.L income_statement (annual, 2025-12-31) — Basic Average Shares: 274347963.00
GENI.L income_statement (annual, 2025-12-31) — Basic EPS: -0.02
GENI.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1110000.00
GENI.L balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 414000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 414000.00
GENI.L cash_flow (annual, 2025-12-31) — Capital Expenditure: -44000.00
GENI.L balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 146000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 146000.00
GENI.L balance_sheet (annual, 2025-12-31) — Capital Stock: 2869000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2869000.00
GENI.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 827000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 827000.00
GENI.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 895000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 895000.00
GENI.L cash_flow (annual, 2025-12-31) — Change In Inventory: 53000.00
GENI.L cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -13000.00
GENI.L cash_flow (annual, 2025-12-31) — Change In Payable: 815000.00
GENI.L cash_flow (annual, 2025-12-31) — Change In Receivables: -261000.00
GENI.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 594000.00
GENI.L cash_flow (annual, 2025-12-31) — Changes In Cash: -483000.00
GENI.L balance_sheet (annual, 2025-12-31) — Common Stock: 2869000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 2869000.00
GENI.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 124000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 124000.00
GENI.L cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3743000.00
GENI.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 1272000.00
GENI.L balance_sheet (annual, 2025-12-31) — Current Assets: 2042000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 2042000.00
GENI.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 95000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 95000.00
GENI.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 95000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 95000.00
GENI.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 2200000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2200000.00
GENI.L cash_flow (annual, 2025-12-31) — Depreciation: 163000.00
GENI.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 266000.00
GENI.L income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 266000.00
GENI.L income_statement (annual, 2025-12-31) — Depreciation Income Statement: 163000.00
GENI.L income_statement (annual, 2025-12-31) — Diluted Average Shares: 274347963.00
GENI.L income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
GENI.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — EBIT: -5850000.00
GENI.L income_statement (annual, 2025-12-31) — EBITDA: -5584000.00
GENI.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 200000.00
GENI.L cash_flow (annual, 2025-12-31) — End Cash Position: 827000.00
GENI.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3642000.00
GENI.L cash_flow (annual, 2025-12-31) — Free Cash Flow: -4168000.00
GENI.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 1746000.00
GENI.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 98000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 98000.00
GENI.L balance_sheet (annual, 2025-12-31) — Gross PPE: 1248000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1248000.00
GENI.L income_statement (annual, 2025-12-31) — Gross Profit: 1804000.00
GENI.L income_statement (annual, 2025-12-31) — Interest Expense: 13000.00
GENI.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 13000.00
GENI.L income_statement (annual, 2025-12-31) — Interest Income: 43000.00
GENI.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 43000.00
GENI.L cash_flow (annual, 2025-12-31) — Interest Received Cfi: 43000.00
GENI.L balance_sheet (annual, 2025-12-31) — Inventory: 73000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Inventory: 73000.00
GENI.L balance_sheet (annual, 2025-12-31) — Invested Capital: 124000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 124000.00
GENI.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1000.00
GENI.L cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3743000.00
GENI.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 51000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 51000.00
GENI.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 51000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 51000.00
GENI.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 834000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 834000.00
GENI.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3743000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5705000.00
GENI.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -5863000.00
GENI.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -5705000.00
GENI.L income_statement (annual, 2025-12-31) — Net Interest Income: 30000.00
GENI.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 30000.00
GENI.L balance_sheet (annual, 2025-12-31) — Net PPE: 237000.00
GENI.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 237000.00